中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2015, 27(3): 237-248
我国肝癌研究的现状与前景
吕桂帅1,陈 磊1,王红阳1,2*
(1 第二军医大学东方肝胆外科医院,上海 200438;2 国家肝癌科学中心,上海 201805)
摘 要:肝癌是病死率最高的恶性肿瘤之一。我国每年约有38.3 万人死于肝癌,占全球肝癌死亡病例数的51%,严峻的形势给我国的社会和医疗带来了沉重的负担。不断增加的科研经费投入为我国肝癌研究带来了快速发展的新机遇。主要介绍近年来我国科学家在肝癌流行病学、发病机制及诊疗方面取得的主要进展。
 
Research progress and prospect of liver cancer in China
LV Gui-Shuai1, CHEN Lei1, WANG Hong-Yang1,2*
(1 Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China; 2 National Center for Liver Cancer, Shanghai 201805, China)
Abstract: Primary liver cancer is the leading cause of cancer-related mortality in China, with approximately 383 000 deaths annually, accounting for 51% of the mortality of liver cancer worldwide. It is a global burden for Chinese society and public health to face with this heavy situation. Chinese scientists are industriously unveiling the mechanisms of liver cancer with ever-accelerated science and technology. Here we summarize recent findings in the field of liver cancer research and outlook involving mechanism, diagnosis and therapy in China.
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第3068700 位访问者,欢迎!